BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22429913)

  • 1. Multiple endocrine neoplasias type 2B and RET proto-oncogene.
    Martucciello G; Lerone M; Bricco L; Tonini GP; Lombardi L; Del Rossi CG; Bernasconi S
    Ital J Pediatr; 2012 Mar; 38():9. PubMed ID: 22429913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.
    Jasim S; Ying AK; Waguespack SG; Rich TA; Grubbs EG; Jimenez C; Hu MI; Cote G; Habra MA
    Thyroid; 2011 Feb; 21(2):189-92. PubMed ID: 21186952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and therapeutic approach to multiple endocrine neoplasia type 2B in pediatric patients.
    Torre M; Martucciello G; Ceccherini I; Lerone M; Aicardi M; Gambini C; Jasonni V
    Pediatr Surg Int; 2002 Sep; 18(5-6):378-83. PubMed ID: 12415360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Diagnosis and Treatment of Multiple Endocrine Neoplasia Type 2B in Ethnic Han Chinese.
    Zhang ZW; Guo X; Qi XP
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):534-543. PubMed ID: 32914730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
    Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
    Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET protooncogene mutational analysis in multiple endocrine neoplasia syndrome type 2B: case report and review of the literature.
    Kahn MA; Cote GJ; Gagel RF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Sep; 82(3):288-94. PubMed ID: 8884827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ line mutation in the RET proto-oncogene associated with familial multiple endocrine neoplasia type 2B: a case report.
    Ishida O; Zeki K; Morimoto I; Yamamoto S; Fujihira T; Eto S
    Jpn J Clin Oncol; 1995 Jun; 25(3):104-8. PubMed ID: 7596047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
    Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
    J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 2.
    Gertner ME; Kebebew E
    Curr Treat Options Oncol; 2004 Aug; 5(4):315-25. PubMed ID: 15233908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene.
    Frilling A; Weber F; Tecklenborg C; Broelsch CE
    Langenbecks Arch Surg; 2003 Mar; 388(1):17-26. PubMed ID: 12690476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
    Romei C; Tacito A; Molinaro E; Agate L; Bottici V; Viola D; Matrone A; Biagini A; Casella F; Ciampi R; Materazzi G; Miccoli P; Torregrossa L; Ugolini C; Basolo F; Vitti P; Elisei R
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):892-9. PubMed ID: 25440022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.
    Gimm O; Marsh DJ; Andrew SD; Frilling A; Dahia PL; Mulligan LM; Zajac JD; Robinson BG; Eng C
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3902-4. PubMed ID: 9360560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET oncogene mutations in medullary thyroid carcinoma in Mexican families.
    González B; Salcedo M; Medrano ME; Mantilla A; Quiñónez G; Benítez-Bribiesca L; Rodríguez-Cuevas S; Cabrera L; de León B; Altamirano N; Tapia J; Dawson B
    Arch Med Res; 2003; 34(1):41-9. PubMed ID: 12604374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.